From October 31, 2023 to December 31, 2023, the company has repurchased 1,985,118 shares, representing 0.47% for CNY 38.99 million. With this, the company has completed the repurchase of 1,985,118 shares, representing 0.47% for CNY 38.99 million under the buyback announced on October 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.62 CNY | -4.90% | -7.41% | -22.72% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.72% | 738M | |
+45.88% | 754B | |
+40.95% | 630B | |
-5.61% | 352B | |
+19.81% | 331B | |
+9.33% | 298B | |
+18.45% | 250B | |
+11.88% | 217B | |
-0.78% | 216B | |
+6.56% | 164B |
- Stock Market
- Equities
- 301263 Stock
- News Guangdong Taienkang Pharmaceutical Co., Ltd.
- Tranche Update on Guangdong Taienkang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on October 31, 2023.